The 22G Franseen Needle Combined With Different Aspiration Techniques for Endoscopic Ultrasound-guided Fine-needle Biopsy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorChanghai Hospital

About this trial

The goal of this clinical study is to compare the tissue adequacy, cellularity, blood contamination, accuracy, sensitivity, specificity of the 22G Franseen needle combined with three different suction techniques (dry-suction, wet-suction, and slow-pull) in Endoscopic ultrasound-guided fine-needle biopsy for solid pancreatic lesions.

Eligibility criteria

Qualifiers

None

Disqualifiers

contraindications to endoscopy, such as severe cardiovascular and cerebrovascular diseases;

bleeding coagulation dysfunction (prothrombin international normalized ratio ≥1.5, platelet count ≤ 50 000) or use of antiplatelet drugs;

confirmed pregnancy or possible pregnancy;

pathological diagnosis has been obtained by other methods;

Trial design

Treatments tested in this trial

  • ABC
  • ACB
  • BAC
  • BCA
  • CAB
  • CBA

Treatment groups

270 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators